C000010380 Holdings — Biotechnology Fund
All 74 reported holdings of Biotechnology Fund (C000010380) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Abbvie, Inc. | 8.15% | $1.10M |
| Amgen, Inc. | 5.04% | $679.34K |
| Gilead Sciences, Inc. | 4.49% | $604.66K |
| Vertex Pharmaceuticals, Inc. | 4.31% | $581.17K |
| Regeneron Pharmaceuticals, Inc. | 2.93% | $394.70K |
| Revolution Medicines, Inc. | 2.47% | $333.55K |
| Alnylam Pharmaceuticals, Inc. | 2.36% | $317.59K |
| Beone Medicines Ltd. | 2.17% | $292.38K |
| Moderna, Inc. | 2.15% | $289.22K |
| Biogen, Inc. | 2.12% | $286.28K |
| Natera, Inc. | 2.11% | $285.02K |
| Royalty Pharma PLC | 2.01% | $270.82K |
| Illumina, Inc. | 1.93% | $260.40K |
| Insmed, Inc. | 1.79% | $241.17K |
| United Therapeutics Corp. | 1.72% | $231.90K |
| Guardant Health, Inc. | 1.72% | $231.35K |
| Roivant Sciences Ltd. | 1.66% | $223.24K |
| Incyte Corp. | 1.61% | $217.65K |
| Viatris, Inc. | 1.55% | $208.93K |
| Neurocrine Biosciences, Inc. | 1.52% | $204.94K |
| Argenx SE | 1.48% | $199.47K |
| Jazz Pharmaceuticals PLC | 1.41% | $190.61K |
| Bridgebio Pharma, Inc. | 1.38% | $186.13K |
| Ionis Pharmaceuticals, Inc. | 1.35% | $181.97K |
| Cytokinetics, Inc. | 1.35% | $181.71K |
| Exelixis, Inc. | 1.33% | $179.12K |
| Alkermes PLC | 1.31% | $176.83K |
| Arrowhead Pharmaceuticals, Inc. | 1.25% | $167.99K |
| Biomarin Pharmaceutical, Inc. | 1.24% | $166.80K |
| Astrazeneca PLC | 1.22% | $164.97K |
| Halozyme Therapeutics, Inc. | 1.17% | $157.64K |
| Biontech SE | 1.16% | $156.14K |
| Crispr Therapeutics AG | 1.16% | $155.82K |
| Vaxcyte, Inc. | 1.15% | $155.50K |
| Tg Therapeutics, Inc. | 1.08% | $145.98K |
| Medpace Holdings, Inc. | 1.03% | $138.75K |
| Apogee Therapeutics, Inc. | 1.02% | $137.24K |
| Cogent Biosciences, Inc. | 1.00% | $134.99K |
| Twist Bioscience Corp. | 0.98% | $132.61K |
| Ptc Therapeutics, Inc. | 0.98% | $132.55K |
| Nuvalent, Inc. | 0.98% | $132.39K |
| Scholar Rock Holding Corp. | 0.98% | $132.38K |
| Axsome Therapeutics, Inc. | 0.96% | $129.24K |
| Cg Oncology, Inc. | 0.96% | $128.88K |
| Krystal Biotech, Inc. | 0.92% | $124.51K |
| Viking Therapeutics, Inc. | 0.90% | $120.70K |
| Travere Therapeutics, Inc. | 0.90% | $120.66K |
| Protagonist Therapeutics, Inc. | 0.89% | $119.39K |
| Ascendis Pharma A/s | 0.88% | $119.22K |
| Veracyte, Inc. | 0.88% | $118.16K |
| Liquidia Corp. | 0.86% | $116.17K |
| Kymera Therapeutics, Inc. | 0.83% | $112.15K |
| Madrigal Pharmaceuticals, Inc. | 0.79% | $106.85K |
| Ultragenyx Pharmaceutical, Inc. | 0.77% | $103.71K |
| Beam Therapeutics, Inc. | 0.74% | $100.04K |
| Immunitybio, Inc. | 0.74% | $99.47K |
| Mirum Pharmaceuticals, Inc. | 0.74% | $99.39K |
| Praxis Precision Medicines, Inc. | 0.72% | $97.09K |
| Rhythm Pharmaceuticals, Inc. | 0.71% | $96.26K |
| Acadia Pharmaceuticals, Inc. | 0.71% | $95.94K |
| Intellia Therapeutics, Inc. | 0.65% | $87.32K |
| Arcutis Biotherapeutics, Inc. | 0.63% | $84.61K |
| Recursion Pharmaceuticals, Inc. | 0.55% | $73.64K |
| Sarepta Therapeutics, Inc. | 0.54% | $73.07K |
| Dreyfus Treasury Obligations Cash Management | 0.54% | $72.52K |
| Summit Therapeutics, Inc. | 0.53% | $71.55K |
| Legend Biotech Corp. | 0.50% | $67.75K |
| Adma Biologics, Inc. | 0.50% | $67.70K |
| Celcuity, Inc. | 0.45% | $60.89K |
| Merrill Lynch, Pierce, Fenner & Smith Incorporated | 0.44% | $59.21K |
| J.p. Morgan Securities LLC | 0.44% | $59.21K |
| Grail, Inc. | 0.38% | $51.27K |
| Sanofi SA - Cvr | 0.00% | $0 |
| Akero Therapeutics Inc | 0.00% | $0 |
C000010380 overview: performance, fees, allocation and SEC filings